Vimarsana
Biggest News Aggregation in the World

Page 3 - Accelerated Approval Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerated Approval Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerated Approval Program Today - Breaking & Trending Today

StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug - Vimarsana News

StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug

Mixed votes from an FDA advisory panel may help Biogen secure accelerated approval of ALS drug tofersen, licensed from Ionis Pharmaceuticals.

'Pregnancy Isn't an Illness': Judge to Decide 'Soon' if FDA Violated Safety Rules on Abortion Drug - Vimarsana News

'Pregnancy Isn't an Illness': Judge to Decide 'Soon' if FDA Violated Safety Rules on Abortion Drug

A federal judge pressed both sides in a hearing on Wednesday questioning FDA approval of an abortion drug.

Source: cbn.com
HHS to Create New Potential Medicare Pricing Models for Cell and Gene Therapy, Drugs Subject to Accelerated FDA Approval, and "High-Value" Generics | Goodwin - Vimarsana News

HHS to Create New Potential Medicare Pricing Models for Cell and Gene Therapy, Drugs Subject to Accelerated FDA Approval, and "High-Value" Generics | Goodwin

On February 14, 2023, the U.S. Department of Health and Human Services (HHS) published a report identifying three models that the Center for Medicare & Medicaid Services’ (CMS) Center...

Cornyn Blasts Biden Admin's Innovation-Killing Drug Pricing Model - Vimarsana News

Cornyn Blasts Biden Admin's Innovation-Killing Drug Pricing Model

If proposed and finalized as described, this profound policy shift would inevitably chill incentives for leveraging the FDA’s game-changing expedited regulatory avenue, which has served patients with life-threatening diseases for decades. Later approvals and access delays would follow.

A Revolution in the Treatment Landscape of AD - Vimarsana News

A Revolution in the Treatment Landscape of AD

Andrew N. Wilner, MD, and Richard J. Caselli, MD, discuss developments in the treatment of Alzheimer's disease.